Markus A. Seeliger
Affiliations: | Molecular and Cellular Pharmacology | Stony Brook University, Stony Brook, NY, United States |
Area:
Pharmacy, Molecular BiologyGoogle:
"Markus Seeliger"Parents
Sign in to add mentorAlan Roy Fersht | grad student | (Chemistry Tree) | |
John Kuriyan | post-doc | UC Berkeley (Chemistry Tree) |
Children
Sign in to add traineeGeorge Georghiou | grad student | 2014 | SUNY Stony Brook |
Sukrit Singh | post-doc | Stony Brook University Medical Center (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lee JY, Gebauer E, Seeliger MA, et al. (2024) Allo-targeting of the kinase domain: Insights from in silico studies and comparison with experiments. Current Opinion in Structural Biology. 84: 102770 |
Outhwaite IR, Singh S, Berger BT, et al. (2023) Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting. Elife. 12 |
Outhwaite IR, Seeliger MA. (2023) Probing conformational dynamics to understand kinase inhibition. Elife. 12 |
Ayaz P, Lyczek A, Paung Y, et al. (2023) Structural mechanism of a drug-binding process involving a large conformational change of the protein target. Nature Communications. 14: 1885 |
Kan Y, Paung Y, Seeliger MA, et al. (2023) Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1. Cells. 12 |
Kan Y, Paung Y, Kim Y, et al. (2023) Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. Biochemistry |
Mingione VR, Paung Y, Outhwaite IR, et al. (2023) Allosteric regulation and inhibition of protein kinases. Biochemical Society Transactions. 51: 373-385 |
Outhwaite IR, Singh S, Berger BT, et al. (2023) Death by a Thousand Cuts â€" Combining Kinase Inhibitors for Selective Target Inhibition and Rational Polypharmacology. Biorxiv : the Preprint Server For Biology |
Sridaran D, Chouhan S, Mahajan K, et al. (2022) Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance. Nature Communications. 13: 6929 |
Peterson AA, Rangwala AM, Thakur MK, et al. (2022) Discovery and molecular basis of subtype-selective cyclophilin inhibitors. Nature Chemical Biology |